Willard, F. S., Douros, J. D., Gabe, M. B., Showalter, A. D., Wainscott, D. B., Suter, T. M., . . . Sloop, K. W. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI insight, 5(17), . https://doi.org/10.1172/jci.insight.140532
Citace podle Chicago (17th ed.)Willard, Francis S., et al. "Tirzepatide Is an Imbalanced and Biased Dual GIP and GLP-1 Receptor Agonist." JCI Insight 5, no. 17 (2020). https://doi.org/10.1172/jci.insight.140532.
Citace podle MLA (9th ed.)Willard, Francis S., et al. "Tirzepatide Is an Imbalanced and Biased Dual GIP and GLP-1 Receptor Agonist." JCI Insight, vol. 5, no. 17, 2020, https://doi.org/10.1172/jci.insight.140532.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..